Legal & General Group
IMMX icon

Legal & General Group’s Immix Biopharma IMMX Stock Holding History

Legal & General Group’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Buy
+3,985
New +$37K ﹤0.01% 2833

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Legal & General Group's IMMX Position: Q2 2026 in Review

Legal & General Group opened a new position in Immix Biopharma (IMMX) in Q2 2026: 3,985 shares worth $41.1K. The stake represents ﹤0.01% of the portfolio and ranks #2833 among its holdings.

109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Legal & General Group held 3,985 shares of Immix Biopharma worth $41.1K as of Q2 2026.
  • Immix Biopharma was a new Legal & General Group position in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2833 holding.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.